HM-72524

N/A

Report date: 2026/01/23 17:55:22

Base Information

Drug NameHM-72524
Drug Alias Namelipid nanoparticle mRNA vaccine (Hanmi Pharmaceutical)mRNA vaccine (Hanmi Pharmaceutical)SARS-CoV-2 mRNA vaccine (Hanmi Pharmaceutical)SARS-CoV-2 vaccine (Hanmi Pharmaceutical)HM-72524
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A